We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ose Immunotherapeutics Sa | LSE:0RAD | London | Ordinary Share | FR0012127173 | ORPHAN SYNERGY EUROPE IMMUNOTHERAPEUTICS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.12 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 2.23M | -23M | -1.0624 | -6.52 | 89.2M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 06/1/2025 | 17:00 | UKREG | Ose Immunotherapeutics : Informations relatives au nombre total de droits.. |
| 18/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2.. |
| 18/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de .. |
| 11/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage.. |
| 11/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®,.. |
| 04/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits.. |
| 02/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité.. |
| 02/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics Strengthens Leadership and Executive Committee |
| 04/11/2024 | 17:00 | UKREG | Informations relatives au nombre total de droits de vote et d’actions.. |
| 04/11/2024 | 06:30 | UKREG | OSE Immunotherapeutics Announces Statistically Significant and Clinically.. |
1 Year Ose Immunotherapeutics Chart |
Intraday Ose Immunotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
